
USPH Stock Forecast & Price Target
USPH Analyst Ratings
Bulls say
US Physical Therapy is a strong and well-established company with a solid financial track record. Revenue and EBITDA both exceeded projections and while profitability may have been slightly lower than expected, it is still within the company's guidance. With a diversified payment source and continued growth in their Physical therapy operations and Industrial injury prevention services, US Physical Therapy is well-positioned for future success.
Bears say
US Physical Therapy is a company with a diverse revenue stream, but its reliance on managed care programs, commercial health insurance, and Medicare/Medicaid makes it vulnerable to any changes in these payment sources. Despite potential growth through hospital partnerships and a positive 2026 outlook, the company has already experienced Medicaid rate pressure in Q1 and may continue to face pricing headwinds for its Medicare business. Additionally, potential growth opportunities through partnerships may take time to fully contribute to revenue.
This aggregate rating is based on analysts' research of U.S. Physical Therapy and is not a guaranteed prediction by Public.com or investment advice.
USPH Analyst Forecast & Price Prediction
Start investing in USPH
Order type
Buy in
Order amount
Est. shares
0 shares